Annual Scientific Meeting 2024
Annual Scientific Meeting
The Melanoma and Skin Cancer Trials 2024 Annual Scientific Meeting will bring together leading figures in melanoma and skin cancer clinical trials to share the latest findings and foster further innovative research.
The full-day program will feature international keynote speakers, presentations on Melanoma and Skin Cancer Trials clinical research, and consumer sessions.
The Melanoma and Skin Cancer Trials 2024 Annual Scientific Meeting will be a satellite meeting of the Australasian Melanoma Conference (AMC), held 25-26 October 2024, Hyatt Regency, Sydney.
Networking Event
Drinks and canapés will be held after the Melanoma and Skin Cancer Trials 2024 Annual Scientific Meeting to facilitate networking.
Details
Annual Scientific Meeting: 9am – 5pm TBC
Networking Event: 5pm – 6pm TBC
Date: Thursday, 24 October 2024
Venue: Hyatt Regency, Sydney
Registration
Registrations will be through the Australasian Melanoma Conference registration portal. Register your interest to attend here.
Registration fees
Full registration for medical practitioners: $150
Concession for non-medical practitioners: $75
Registration fees include access to the Annual Scientific Meeting and the Networking Event.
Seats at the Annual Scientific Meeting are limited to the first 180 registrations.
Entry to the Networking Event are limited to the first 100 registrations.
Speakers
The program features two international keynote speakers and a stellar line-up of leaders in their field who will discuss the latest clinical research in melanoma and skin cancer. Updates on MASC Trials’ research portfolio and opportunities for new research collaborations will form part of the meeting. Consumer presentations will also provide a unique perspective on our patient engagement.
International keynote speakers
TBC
Speakers - Melanoma clinical trials
TBC
Speakers - Merkel cell carcinoma clinical trials
TBC
Speakers - Uveal melanoma clinical trials
TBC
Speakers - Keratinocyte cancer clinical trials
TBC
Speakers - Primary and supportive care
TBC
Speaker - Melanoma and Skin Cancer Trials operations
Gabrielle Byars
Gabrielle Byars is Chief Executive of MASC Trials. She brings 15 years’ of cross-industry management experience in US- and Australian-led, multi-centre clinical studies and early phase investigator-initiated research in diabetes (device) and gastroenterology (vaccine). She has a biomedical background and notable success in technical projects with a variety of university and industry stakeholders in the biotechnology and medical technology industries.
Talk: Update on MASC Trials operations
Meeting Chair
Prof Mark Shackelton
Prof Shackleton is Chair of the Melanoma and Skin Cancer Trials Board of Directors. He is also Director of Oncology at Alfred Health, Co-Director of Monash Partners Comprehensive Cancer Consortium, Professor of Oncology at Monash University, Director of Cancer Trials Australia, and a Victorian Cancer Agency Clinical Research Fellow. After training in medical oncology in Melbourne, he undertook PhD studies at the Walter and Eliza Hall Institute and post-doctoral work at the University of Michigan, receiving several major prizes including the 2012 Australian Science Minister’s Prize for Life Scientist of the Year.
Who should attend?
The meeting is relevant to those who represent the many disciplines critical to our work including:
Oncologists
Surgeons
Radiation specialists
Nurses
Dermatologists
Allied health professionals
Health economists
Epidemiologists
Statisticians
Ophthalmologists
Research scientists
Research students
Clinical trial coordinators
Data managers
Consumers / patient advocates and their families
Sponsorship opportunities available
Melanoma and Skin Cancer Trials offers a range of benefits to sponsors of its Annual Scientific Meeting. If your company is interested in sponsoring this event, please email hello@masc.org.au for further details. Customised sponsorship packages are available.
Melanoma and Skin Cancer Trials ASM 2024 organising committee
- Prof Mark Shackleton, Board Chair of Melanoma and Skin Cancer Trials, Director of Oncology at Alfred Health, Professor of Oncology at Monash University, and Director of Cancer Trials Australia
- Alison Button-Sloan, Chair, Melanoma and Skin Cancer Trials Consumer Advisory Panel
- Gabrielle Byars, CEO, Melanoma and Skin Cancer Trials
- Merrin Morrison, Marketing and Communications Manager, Melanoma and Skin Cancer Trials
Contact
Email: hello@masc.org.au
Phone: +61 3 9903 9022